Funding for this research was provided by:
National Natural Science Foundation of China (82173452)
National Natural Science Foundation of Fujian Province, China (2021J01658, 2020J011014)
Special Projects of the Central Government Guiding Local Science and Technology Development (2021L3018)
Fujian Provincial Health Technology Project (2021CXA011)
Received: 9 March 2022
Accepted: 30 May 2022
First Online: 14 June 2022
: The XAHFMU Ethics Committee approved the study protocol (No. 2022KY045). The purpose along with the methods of this research were fully disclosed to all eligible patients. The subjects granted a written informed consent form. All clinical data is collected in a confidential manner by research members. The study is conducted in accordance with the Helsinki Declaration, the International Conference of Harmonization Good Clinical Practice guidelines, and local regulatory requirements.
: Not applicable.